Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia.
Saved in:
| Title: | Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia. |
|---|---|
| Authors: | Berger MD; Department of Medical Oncology, University Hospital and University of Berne, Berne, Switzerland., Heini AD; Department of Medical Oncology, University Hospital and University of Berne, Berne, Switzerland., Seipel K; Department of Clinical Research, University Hospital and University of Berne, Berne, Switzerland., Mueller B; Department of Clinical Research, University Hospital and University of Berne, Berne, Switzerland., Angelillo-Scherrer A; Department of Hematology, University Hospital and University of Berne, Berne, Switzerland., Pabst T; Department of Medical Oncology, University Hospital and University of Berne, Berne, Switzerland. |
| Source: | Hematological oncology [Hematol Oncol] 2017 Dec; Vol. 35 (4), pp. 789-796. Date of Electronic Publication: 2016 Jun 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1099-1069 |
|---|---|
| DOI: | 10.1002/hon.2307 |
